# To Compare the Efficacy and Safety of Clindamycin Phosphate 1.2% / Benzoyl Peroxide 5% Gel of CHL Versus DUAC® Gel

> **NCT02005666** · PHASE3 · COMPLETED · sponsor: **Zydus Lifesciences Limited** · enrollment: 850 (actual)

## Conditions studied

- Acne Vulgaris

## Interventions

- **DRUG:** Clindamycin Phosphate 1.2% / Benzoyl Peroxide 5% Gel
- **DRUG:** DUAC® Gel
- **DRUG:** Placebo

## Key facts

- **NCT ID:** NCT02005666
- **Lead sponsor:** Zydus Lifesciences Limited
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2013-11
- **Primary completion:** 2016-09-28
- **Final completion:** 2016-09-28
- **Target enrollment:** 850 (ACTUAL)
- **Last updated:** 2020-10-14


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02005666

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02005666, "To Compare the Efficacy and Safety of Clindamycin Phosphate 1.2% / Benzoyl Peroxide 5% Gel of CHL Versus DUAC® Gel". Retrieved via AI Analytics 2026-05-25 from https://api.ai-analytics.org/clinical/NCT02005666. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*